Zevra Therapeutics, Inc. (FRA:1GDA)
Germany · Delayed Price · Currency is EUR 7.55
+0.25 (3.42%)
At close: Nov 28, 2025
Zevra Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 35.33 | -105.51 | -46.05 | -26.77 | -8.56 | -12.76 | Upgrade |
Depreciation & Amortization | 5.34 | 6.39 | 1.01 | 0.94 | 0.26 | 0.27 | Upgrade |
Other Amortization | - | - | - | - | 0.15 | 2.31 | Upgrade |
Loss (Gain) From Sale of Assets | -148.11 | 0.22 | 0.16 | 0.01 | 0.08 | 0.25 | Upgrade |
Asset Writedown & Restructuring Costs | 58.71 | - | - | 17.66 | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -3.2 | -0.87 | -0.61 | 0.58 | - | - | Upgrade |
Stock-Based Compensation | 12.52 | 15.38 | 6.18 | 4.52 | 2.74 | 2.69 | Upgrade |
Other Operating Activities | 37.32 | 21.37 | -0.1 | -15.25 | 16.13 | 4.93 | Upgrade |
Change in Accounts Receivable | -8.33 | 6.87 | -9.08 | -6.77 | 1.05 | -0.71 | Upgrade |
Change in Inventory | -5.5 | -8.87 | 0.21 | 0.15 | - | - | Upgrade |
Change in Accounts Payable | -9.01 | -3.6 | 11.13 | 3.13 | -1.11 | 0.93 | Upgrade |
Change in Other Net Operating Assets | 1.56 | -1.04 | 3.63 | 3.09 | -0.3 | 0.16 | Upgrade |
Operating Cash Flow | -23.36 | -69.67 | -33.54 | -18.72 | 10.44 | -1.94 | Upgrade |
Capital Expenditures | -0.87 | - | -0.3 | -0.09 | -0.1 | -0.03 | Upgrade |
Cash Acquisitions | - | - | -30.4 | -14.09 | - | - | Upgrade |
Investment in Securities | -131.29 | -16.16 | 13.31 | -22.54 | -15.42 | - | Upgrade |
Other Investing Activities | 144 | -6 | - | - | - | - | Upgrade |
Investing Cash Flow | 12.43 | -22.16 | -17.39 | -36.72 | -15.52 | -0.03 | Upgrade |
Long-Term Debt Issued | - | 60.07 | 43.69 | 14.07 | - | 0.78 | Upgrade |
Long-Term Debt Repaid | - | -43.13 | -18.1 | -1.32 | -38.1 | -0.23 | Upgrade |
Net Debt Issued (Repaid) | -0.37 | 16.94 | 25.59 | 12.75 | -38.1 | 0.55 | Upgrade |
Issuance of Common Stock | 10.69 | 67.26 | 6.32 | 0.32 | 158.24 | 2.3 | Upgrade |
Repurchase of Common Stock | - | - | -3.45 | -4.72 | -2.81 | - | Upgrade |
Other Financing Activities | - | -2.09 | - | - | -4.22 | -0.12 | Upgrade |
Financing Cash Flow | 10.31 | 82.11 | 28.46 | 8.35 | 113.11 | 2.74 | Upgrade |
Foreign Exchange Rate Adjustments | 1.02 | 0.45 | 0.04 | 0.2 | - | - | Upgrade |
Net Cash Flow | 0.4 | -9.26 | -22.42 | -46.88 | 108.02 | 0.77 | Upgrade |
Free Cash Flow | -24.23 | -69.67 | -33.83 | -18.81 | 10.34 | -1.97 | Upgrade |
Free Cash Flow Margin | -28.71% | -295.04% | -123.20% | -185.12% | 36.08% | -14.84% | Upgrade |
Free Cash Flow Per Share | -0.43 | -1.51 | -0.95 | -0.55 | 0.35 | -0.49 | Upgrade |
Cash Interest Paid | 5.59 | 5.26 | 0.46 | 0.32 | 0.22 | 0.08 | Upgrade |
Levered Free Cash Flow | -30.06 | -36.36 | -10.32 | -10 | 6.31 | -0.86 | Upgrade |
Unlevered Free Cash Flow | -24.92 | -31.77 | -9.39 | -9.79 | 6.39 | 1.27 | Upgrade |
Change in Working Capital | -21.27 | -6.64 | 5.88 | -0.41 | -0.36 | 0.37 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.